tm
Seeing Is Believing
tm
Seeing Is Believing
RXRX is currently covered by 6 analysts with an average price target of $11.32. This is a potential upside of $5.29 (87.73%) from yesterday's end of day stock price of $6.03.
Recursion Pharmaceuticals's activity chart (see below) currently has 20 price targets and 46 ratings on display. The stock rating distribution of RXRX is 18.52% HOLD and 81.48% BUY.
Analysts average stock forecasts to be materialized ratio is 62.16% with an average time for these price targets to be met of 49.29 days.
Highest price target for RXRX is $12, Lowest price target is $8, average price target is $11.32.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 11-Dec-2024. First documented stock forecast 11-May-2021.
Currently out of the existing stock ratings of RXRX, 5 are a HOLD (18.52%), 22 are a BUY (81.48%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$4.05 (58.27%)
$11
9 days ago
(11-Dec-2024)
2/17 (11.76%)
$3.43 (45.31%)
71
Hold
$8
$1.05 (15.11%)
$8
3 months 17 days ago
(03-Sep-2024)
5/6 (83.33%)
$1.93 (31.80%)
69
Buy
$12
$5.05 (72.66%)
$16
5 months 9 days ago
(11-Jul-2024)
2/5 (40%)
$4.32 (56.25%)
35
Hold
$10
$3.05 (43.88%)
$32
1 years 1 months 7 days ago
(13-Nov-2023)
2/2 (100%)
$4.17 (71.53%)
35
Buy
$33
$26.05 (374.82%)
$38
1 years 5 months 8 days ago
(12-Jul-2023)
0/3 (0%)
$20.92 (173.18%)
What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?
Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?
Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?
